Analytical Data
-
基因名
INGAP
- Application
-
别名
Islet neogenesis-associated protein
-
种属
Golden hamster
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q92778
-
表达区间
27-175aa
-
分子量
22.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
INGAP (Islet Neogenesis Associated Protein) is a key protein implicated in the regeneration of pancreatic beta cells, which are crucial for insulin production and glucose metabolism. Research into INGAP has gained significant momentum due to the rising prevalence of diabetes, a condition that results from the dysfunction or loss of beta cells. In the early 1990s, INGAP was identified as a protein associated with islet neogenesis, the process by which new islet cells form in the pancreas. Subsequent studies have demonstrated that INGAP not only plays a role in promoting beta-cell proliferation under certain conditions but may also enhance the survival of these cells. Additionally, the ability of INGAP to stimulate the differentiation of progenitor cells into functional beta cells has raised interest in its potential therapeutic applications for diabetes. Understanding the molecular mechanisms underlying INGAP's action could lead to innovative treatment strategies, including the development of new drugs or regenerative therapies aimed at restoring beta-cell function. Ongoing research is focusing on characterizing the structural properties of INGAP, elucidating its signaling pathways, and testing its efficacy in preclinical models of diabetes. The insights gained from these studies hold promise for advancing our knowledge of pancreatic regeneration and ultimately improving clinical outcomes for patients suffering from diabetes.












